摘要
根据杂质产生的机理,模拟杂质产生的条件,合成了欧盟药典7.8所载非洛地平的3种杂质——2,6-二甲基-4-(2,3-二氯苯基)-3,5-吡啶二甲酸甲乙酯(1),2,6-二甲基-4-(2,3-二氯苯基)-1,4-二氢-3,5-吡啶二甲酸二甲酯(2)和2,6-二甲基-4-(2,3-二氯苯基)-1,4-二氢-3,5-吡啶二甲酸二乙酯(3),其结构经1H NMR和MS确证.1~3的合成,为非洛地平生产、检验、贮存过程中对杂质的控制提供了依据.
Impurity in bulk drugs Felodipin recorded in EP7.8,3,5-pyridinedicarboxylic acid-4-(2,3-dichlorophenyl)-2,6-dimethyl-3-ethyl-5-methyl ester (1),3,5-pyridinedicarboxylic acid-4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-dimethyl ester (2) and 3,5-pyridinedicarboxylic acid4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-diethyl ester (3) were synthesized.The structures were confirmed by 1H NMR and MS.Synthesis of 1 ~ 3 provide the basis for control of the impurity in the process of production,inspection and storage.
出处
《合成化学》
CAS
CSCD
北大核心
2014年第2期268-271,共4页
Chinese Journal of Synthetic Chemistry
关键词
非洛地平
杂质
合成
质量控制
Felodipine
impurity
synthesis
quality control